Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAMBLE: Rivaroxaban vs Apixaban for Menstrual Blood Loss
NCT02829957Phase 3Completed
- Sponsor
- Indiana University
- Start
- Sep 2016
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apixaban in venous thromboembolism (VTE), Atrial fibrillation (AFib), sponsored by Indiana University. Started Sep 2016; status: completed.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02829957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02829957.